Actively Recruiting
Reliability of IUS in Crohn's Disease
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2025-02-18
30
Participants Needed
1
Research Sites
210 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD). In order to incorporate individual parameters in a future definition of transmural healing, and for the consistent application of IUS as a modality to assess treatment outcomes and establish therapeutic targets to ensure comparability between future studies, the inter-observer agreement should be determined for all relevant parameters.
CONDITIONS
Official Title
Reliability of IUS in Crohn's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Crohn's disease evolving for at least 1 months
- Patient older than 18 years
- Patient covered by French national health insurance
- Written informed consent
You will not qualify if you...
- Pregnant women or breastfeeding
- Minor
- Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU d'Amiens
Amiens, France, 80054
Actively Recruiting
Research Team
M
Mathurin Fumery, Pr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here